Search

everythinglearnresearchcommunity

for

Search:↓

Dihydrotestosterone causes p27 protein breakdown in ovarian and breast cancer cells by binding with SKP2.

AGA causes permanent hair loss; minoxidil helps men, finasteride helps men, minoxidil somewhat helps women, estrogens/antiandrogens lack evidence for women.

Effective hair loss treatment in women requires correct diagnosis and can include medications like minoxidil, antiandrogens, and treatments for underlying conditions like PCOS.

Testosterone therapy can help improve sexual desire and function in postmenopausal women but may cause side effects and is not FDA-approved for this use.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Polycystic Ovary Syndrome can cause hair loss and skin issues, and early treatment is important for preventing complications.

Long-term use of dutasteride for enlarged prostate may worsen blood sugar, cholesterol, and erectile dysfunction.

Women with PCOS in North China often have hirsutism and acne, with hirsutism linked to metabolic issues.

Identifying nonclassic congenital adrenal hyperplasia and carriers of CYP21 mutations is challenging, and genetic counseling is recommended due to their prevalence.

The treatment effectively reduced hair growth and was safe for patients with PCOS, but it needs better bleeding control.

Antiandrogens can treat female hormonal conditions, but environmental ones may harm reproductive health.

Dermatologists can help diagnose endocrine disorders like PCOS and metabolic syndrome by looking at skin symptoms.

Inositol was more effective than metformin in improving menstrual cycles and pregnancy rates in PCOS patients.

Finasteride improves hair growth in men with androgenetic alopecia.

Finasteride and minoxidil are effective for hair loss, but continued research is needed for better treatments.

Many women in southern China have polycystic ovary syndrome, with some symptoms differing from Western women.

Minoxidil and finasteride can slow hair loss and stimulate regrowth, but won't restore all lost hair or reverse complete baldness.

Finasteride is a safe, effective treatment for hirsutism with fewer side effects.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

Finasteride effectively reduces hair growth in women with idiopathic hirsutism, but requires careful contraception during treatment.

Women with PCOS often have more body hair, acne, and skin darkening, and these signs are linked to metabolic issues like insulin resistance and high cholesterol.

Combination drug therapy is effective for hirsutism that doesn't improve with just one medication.

Finasteride effectively reduces hair growth in women with polycystic ovary syndrome or idiopathic hirsutism.

New compounds may soon be tested to treat excessive hair growth in women.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Irregular menstrual cycles in teenagers are linked to a higher risk of polycystic ovary syndrome and metabolic syndrome.

Hormonal imbalances, not insulin resistance or dyslipidemia, may be more important in causing acne in women over 25.

Finasteride can have lasting negative effects on brain function and behavior by disrupting neurosteroid production.

Early balding in men is linked to metabolic syndrome, so screening is important for prevention.